SCHEMBL43521

SCHEMBL43521

COc1cccc(CCO)c1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.67
CHRM2 P08172 2/20 0.62
CHRM1 P11229 2/20 0.62
CHRM3 P20309 2/20 0.62
CYP4F2 P78329 2/20 0.61
CYP4A11 Q02928 2/20 0.61
SIGMAR1 Q99720 1/20 0.59
AOC3 Q16853 1/20 0.59
IDO1 P14902 2/20 0.56
AGXT P21549 2/20 0.56
HRH3 Q9Y5N1 1/20 0.56
MTNR1A P48039 1/20 0.55
MTNR1B P49286 1/20 0.55
GABRA1 P14867 1/20 0.54
GABRG2 P18507 1/20 0.54
GABRB3 P28472 1/20 0.54
GABRA3 P34903 1/20 0.54
GABRA2 P47869 1/20 0.54
GABRB2 P47870 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL5332610 0.96 TAAR1 (0.62) TAAR1CHRM2CHRM1CHRM3CYP4F2
SCHEMBL81474 0.89 CHRM2 (0.63) TAAR1CHRM2CHRM1CHRM3SIGMAR1
SCHEMBL30080050 0.87 TAAR1 (0.77) TAAR1CHRM2CHRM1CHRM3SIGMAR1
SCHEMBL723511 0.87 TAAR1 (0.77) TAAR1CHRM2CHRM1CHRM3SIGMAR1
SCHEMBL23266720 0.87 CHRM2 (0.61) TAAR1CHRM2CHRM1CHRM3CYP4F2
SCHEMBL17274721 0.85 HDAC1 (0.62) TAAR1CHRM2CHRM1CHRM3CYP4F2
SCHEMBL15746740 0.85 HDAC1 (0.62) TAAR1CHRM2CHRM1CHRM3CYP4F2
SCHEMBL3164270 0.84 TAAR1 (0.57) TAAR1CHRM2CHRM1CHRM3SIGMAR1
SCHEMBL24041859 0.84 CYP4F2 (0.74) CYP4F2CYP4A11
SCHEMBL96382 0.83 TAAR1 (0.60) TAAR1CHRM2CHRM1CHRM3SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 499 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110144139-B Zinc oxide-based nanoparticle ink and photoelectric device 纳晶科技股份有限公司 2022-01-18 CN claimed
CN-113620788-A Preparation method of 3-methoxy phenethyl bromide 苏州求索生物科技有限公司 2021-11-09 CN claimed
US-9616459-B1 Polymeric coatings for fortification of visible, infrared, and laser optical devices LOCKHEED MARTIN CORPORATION (US) 2017-04-11 US claimed
CN-104531397-A Cleaning solution for sheet glass substrate thinning pre-cleaning, and application thereof HUIJING DISPLAY TECHNOLOGY SUZHOU CO LTD 2015-04-22 CN claimed
CN-101907835-B Detergent composition for photoresists ANJI MICROELECTRONICS SHANGHAI 2013-08-28 CN claimed
US-8497397-B2 Substituted acrylamide derivative and pharmaceutical composition comprising the same DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-07-30 US claimed
CN-101373340-B Cleaning agent of photoresist ANJI MICROELECTRONICS CO LTD 2013-07-10 CN claimed
CN-101614971-B Photoresist cleaning agent ANJI MICROELECTRONICS CO LTD 2013-06-12 CN claimed
EP-1880720-B1 SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAIICHI SANKYO CO LTD (JP) 2013-02-13 EP claimed
US-20120220593-A1 Substituted Acrylamide Derivative and Pharmaceutical Composition Comprising the Same DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-08-30 US claimed
CN-101750914-A Photoresist detergent composition ANJI MICROELECTRONICS SHANGHAI 2010-06-23 CN claimed
CN-101614971-A A kind of photoresist clean-out system ANJI MICROELECTRONICS CO LTD 2009-12-30 CN claimed
US-20090118199-A1 SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAIICHI SANKYO COMPANY , LIMITED (JP) 2009-05-07 US claimed
CN-101373340-A Cleaning agent of photoresist ANJI MICROELECTRONIC SHANGHAI (CN) 2009-02-25 CN claimed
EP-1880720-A1 SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Daiichi Sankyo Company, Limited (JP) 2008-01-23 EP claimed
US-6989052-B1 Phase change ink printing process XEROX CORPORATION (US) 2006-01-24 US claimed
US-20060004123-A1 PHASE CHANGE INK PRINTING PROCESS XEROX CORPORATION 2006-01-05 US claimed
WO-2004111092-A1 MODIFIED ALGINIC ACID OR ALGINIC ACID DERIVATIVES AND THERMOSETTING ANTI-REFLECTIVE COMPOSITIONS THEREOF AZ ELECTRONIC MATERIALS USA CORP. (US) 2004-12-23 WO claimed
US-20040253532-A1 Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof MERCK PATENT GMBH (DE) 2004-12-16 US claimed
US-6613317-B1 In particular northern corn rootworm THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2003-09-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118199-A1 SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME ACR, NAT1, C1S TAAR1 260/4885CHRM2 195/4885CHRM1 152/4885
US-20120220593-A1 Substituted Acrylamide Derivative and Pharmaceutical Composition Comprising the Same ACR, NAT1, C1S TAAR1 260/4885CHRM2 195/4885CHRM1 152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.